Exagen Inc. - stock earnings
XGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -5.6 million USD | 13.8 million USD |
| 2023Q3 | -5.4 million USD | 13.4 million USD |
| 2023Q2 | -5.0 million USD | 14.1 million USD |
| 2023Q1 | -8.3 million USD | 11.2 million USD |
| 2022Q4 | -14.4 million USD | 12.8 million USD |
| 2022Q3 | -2.4 million USD | 14.7 million USD |
| 2022Q2 | -13.9 million USD | 9.0 million USD |
| 2022Q1 | -10.9 million USD | 10.4 million USD |
| 2021Q4 | -7.1 million USD | 12.7 million USD |
| 2021Q3 | -7.2 million USD | 12.3 million USD |
| 2021Q2 | -6.4 million USD | 12.8 million USD |
| 2021Q1 | -6.2 million USD | 10.6 million USD |
| 2020Q4 | -3.5 million USD | 12.7 million USD |
| 2020Q3 | -4.3 million USD | 10.8 million USD |
| 2020Q2 | -3.4 million USD | 8.9 million USD |
| 2020Q1 | -5.6 million USD | 9.6 million USD |
| 2019Q4 | -3.4 million USD | 10.2 million USD |
| 2019Q3 | -3.1 million USD | 10.4 million USD |
| 2019Q2 | -2.8 million USD | 10.5 million USD |
| 2019Q1 | -2.7 million USD | 9.3 million USD |
| 2018Q4 | -1.3 million USD | 9.6 million USD |
| 2018Q3 | -1.8 million USD | 8.2 million USD |
| 2018Q2 | -4.5 million USD | 7.8 million USD |
| 2018Q1 | -5.3 million USD | 6.8 million USD |
| 2015Q4 | -2.5 million USD | 4.4 million USD |
| 2015Q3 | -3.5 million USD | 4.7 million USD |
| 2015Q2 | -9.7 million USD | 4.5 million USD |
| 2015Q1 | -3.5 million USD | 4.4 million USD |
| 2014Q4 | -2.6 million USD | 4.2 million USD |
| 2014Q3 | -4.8 million USD | 3.7 million USD |
| 2014Q2 | -4.0 million USD | 2.4 million USD |
| 2014Q1 | -3.6 million USD | 1.4 million USD |
| 2013Q4 | -6.5 million USD | 1.1 million USD |
| 2013Q3 | -2.4 million USD | 935000 USD |
| 2013Q2 | -2.9 million USD | 664000 USD |
| 2013Q1 | -2.9 million USD | 363000 USD |
XGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -23.7 million USD | 52.5 million USD |
| 2022 | -47.4 million USD | 45.6 million USD |
| 2021 | -26.9 million USD | 48.3 million USD |
| 2020 | -16.7 million USD | 42.0 million USD |
| 2019 | -12.0 million USD | 40.4 million USD |
| 2018 | -8.0 million USD | 32.4 million USD |
| 2017 | -25.6 million USD | 26.8 million USD |
| 2015 | -19.2 million USD | 17.9 million USD |
| 2014 | -15.0 million USD | 11.7 million USD |
| 2013 | -13.5 million USD | 3.1 million USD |
| 2012 | -7.3 million USD | 926000 USD |
XGN
Price: $1.40
52 week price:
Earnings Per Share: -1.34 USD
P/E Ratio: -1.11
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 10300
Market Capitalization: 25.5 million